Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
191 hedge funds and large institutions have $690M invested in Meridian Bioscience Inc in 2018 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 56 increasing their positions, 66 reducing their positions, and 20 closing their positions.
1,215% more call options, than puts
Call options by funds: $2.25M | Put options by funds: $171K
85% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 20
17% more capital invested
Capital invested by funds: $592M → $690M (+$97.9M)
8% more funds holding
Funds holding: 177 → 191 (+14)
15% less repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 66
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
+$13.1M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$7.05M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$4.08M |
| 4 |
WG
Winton Group
London,
United Kingdom
|
+$3.66M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$1.96M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$6.24M |
| 2 |
JP Morgan Chase
New York
|
-$4.87M |
| 3 |
Millennium Management
New York
|
-$4.28M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$3.82M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.55M |
VIVO Hedge Fund Activity: Q4 2018 in Review
191 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q4 2018, worth a combined $690M — up 17% from $592M a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new VIVO positions and 20 closed out — a net gain of 17 holders — while 56 added to existing stakes and 66 trimmed.
The largest buyer was Vaughan Nelson Investment Management, opening a new position worth an estimated $13.1M. The largest seller was AJO LP, exiting entirely with an estimated $6.24M sold.
- 191 institutional investors held Meridian Bioscience Inc (VIVO) as of Q4 2018, up from 177 in Q3 2018.
- Funds reported $690M of Meridian Bioscience Inc stock for Q4 2018, up 17% quarter-over-quarter.
- 37 funds opened new Meridian Bioscience Inc positions in Q4 2018 and 20 closed out, a net change of +17 holders.
- The largest Meridian Bioscience Inc buyer in Q4 2018 was Vaughan Nelson Investment Management, an estimated $13.1M added.
- The largest Meridian Bioscience Inc seller in Q4 2018 was AJO LP, an estimated $6.24M sold.
Based on aggregated 13F filings for Q4 2018.